Prenuvo has raised $190M across 1 funding round, plus 1 undated round.
Prenuvo raised $120 million to advance its preventive health products and fund FDA-cleared AI-powered offerings. Backers include Khosla Ventures and Insight Partners alongside individual investors such as 23andMe's Anne Wojcicki, Nest founder Tony Fadell and Google's former chairman Eric Schmidt.
1 funding round, the latest highlighted.
Prenuvo was founded in 2014, Canada.
No date is disclosed for this round.
No filing has been made.
1 dated round, newest first.
Khosla Ventures
Insight PartnersThe closest healthcare/diagnostics peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Prenuvo is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
